Spanish biotech startup Allbiotech Biotechnologies has launched its Genesys V1 bioreactor, a lower-cost alternative for precision fermentation research. The bioreactor is designed for early-stage testing, process optimization, and scale-up research in food production and is priced at one-third of traditional pharmaceutical bioreactors. The company aims to make bioreactor technology more accessible to food tech startups, research institutions, and universities. The Genesys V1 bioreactor features a 1-liter glass vessel, integrated sensors, and five peristaltic pumps, making it ideal for precision fermentation applications. Allbiotech was founded in 2024 with the goal of reducing the cost barrier associated with precision fermentation equipment. The company plans to scale its operations through a direct-to-consumer sales model, bypassing traditional distributors and reaching customers through digital channels. This innovation has the potential to democratize access to bioreactor technology, promoting the development of sustainable and sustainable food production methods.
Introducing the Allbiotech Bioreactor, a cutting-edge tool for precision fermentation research at an affordable price point.
